Article
- Home
- / DEUCRAVACITINIB IN BULK AND PHARMACEUTICAL DOSAGE FORM
2024-04-17 14:18:52
Aim:- To develop HPLC method which is capable to identify all the possible degradation products of Deucravasitinib. The degradation pathways of Deucravasitinib under forced degradation conditions will be established. Objectives To develop a stability indicating assay method (SIAM) for Deucravasitinib by QbD approach. Conduction of forced degradation studies under different stress conditions as per ICH guidelines. To validate HPLC method for Deucravasitinib as per ICH guidelines.
View Abstract